Delta Air Lines, Vertex Pharmaceuticals, And A Major US Bank Nearing A Breakout Level: CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades', analysts recommended staying long on Vertex Pharmaceuticals, Delta Air Lines, and JPMorgan Chase & Co. Vertex Pharmaceuticals has performed well this year, with Morgan Stanley raising its price target from $305 to $340. Delta Air Lines is also doing well, with positive cash flow, paying down its debt, and raising prices. JPMorgan Chase is expected to report its Q2 results on July 14, 2023. The Cooper Companies was also mentioned as a quality company.
July 07, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The Cooper Companies was mentioned as a quality company.
The positive mention of The Cooper Companies indicates a positive sentiment, but without more specific information, it's difficult to predict the impact on the stock.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEUTRAL IMPACT
JPMorgan Chase is expected to report its Q2 results on July 14, 2023.
The upcoming earnings report for JPMorgan Chase could have a significant impact on the stock, but without further information, it's difficult to predict the direction.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Delta Air Lines is doing well, with positive cash flow, paying down its debt, and raising prices.
The positive comments from the analyst about Delta Air Lines' financial health and pricing power indicate a positive outlook for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vertex Pharmaceuticals has performed well this year, with Morgan Stanley raising its price target from $305 to $340.
The positive comments from the analyst and the raised price target by Morgan Stanley indicate a positive outlook for Vertex Pharmaceuticals.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100